Literature DB >> 8728672

Physiology and evaluation of ureteropelvic junction obstruction.

K R Anderson1, R M Weiss.   

Abstract

Ureteropelvic junction (UPJ) obstruction is not a single anatomic entity but rather a set of processes with multiple causes. In the obstructed system, histologic changes are apparent that have implications for healing. The role of crossing vessels In UPJ obstruction and its treatment is of growing interest. Various methods are available to assess the functional characteristics of the UPJ, of which the diuretic renogram, Whitaker perfusion test, and Doppler ultrasound resistive index may be the most useful. The treatment must be individualized according to the patient's symptoms, the status of renal function, and the potential complications of intervention.

Entities:  

Mesh:

Year:  1996        PMID: 8728672     DOI: 10.1089/end.1996.10.87

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  4 in total

1.  Laparoscopic single-incision triangulated umbilical surgery (SITUS) pyeloplasty: a description of the first 32 cases.

Authors:  Martin Habicher; Theodoros Tokas; Thomas Rw Herrmann; Udo Nagele
Journal:  World J Urol       Date:  2018-05-12       Impact factor: 4.226

2.  Renal Doppler ultrasonography in infants with hydronephrosis.

Authors:  J Svitac; M Zibolen; J Kliment; J Buchanec
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

3.  (99m) T c-DTPA Study to Validate an Experimental Model of Ureteral Obstruction in Rabbits: Preliminary Results.

Authors:  Marcelo Lopes de Lima; Rodolfo Bertti; Juliano César Moro; Fábio Coltro Neto; Ricardo Miyaoka; Adriano Fregonesi; Mariana da Cunha Lopes de Lima; Celso Darío Ramos
Journal:  Adv Urol       Date:  2013-12-29

4.  Learning robotic pyeloplasty without simulators: an assessment of the learning curve in the early robotic era.

Authors:  Mario F Chammas; Anuar I Mitre; Marco A Arap; Nicholas Hubert; Jacques Hubert
Journal:  Clinics (Sao Paulo)       Date:  2019-06-27       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.